i
Important informations

LDI

The Lady Davis Institute for Medical Research

The research arm of the Jewish General Hospital

The LDI is among Canada’s leading health research institutes. Through their fundamental and clinical investigations, our scientists and clinicians make significant discoveries, lead important provincial and national research programs, and train emerging scientists who, themselves, are recognized for the excellence of their work, contributing to the health and well-being of patients in Quebec, Canada, and around the world.

Empowering research excellence and innovation

At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.

Discover our 200+ regular and associated investigators and their research, as well as the many services we provide across the spectrum of the research process.

We offer the 250+ graduate and postdoctoral students who come to the LDI each year an open, collaborative, and multidisciplinary training environment that fosters excellence.

The close collaboration between researchers, clinicians, and patients is at the basis of the most successful research programs and clinical trials at the LDI.

Empowering research excellence and innovation

At the Lady Davis Institute for Medical Research (LDI), equity, diversity and inclusion are at the heart of who we are. We are committed to provide people working in the LDI community with exemplary, highest quality of work and learning environments that are healthy, equitable and inclusive, free from all forms of discrimination and where every person can feel welcomed and recognized, but also involved and contributing to the present and the future of the LDI.

Latest News

Tweets

Psychosocial aspects of disease

Contemplative Practice, Meditation, Neurophenomenology, Placebos, Prayer, Psychedelics

Cancer

Arginine methylation and DNA damage, Breast cancer epigenetics, Drug design, RGG/RG motifs and G-quadruplexes, RNA binding proteins and neurological diseases

Clinical Epidemiology

Appropriate medication use, Clinical Trials in the Primary Care Setting, Delirium, Dementia, Long-term care, Pharmacoepidemiology

Clinical Epidemiology

Cancer pharmacoepidemiology, Drug safety, Large health databases

Cancer

Brain tumor microenvironment, Drug design, Glioma progression, Organ-selective metastasis

Clinical Epidemiology

Hepatitis C, HIV, Implementation research, Implementation science, Infectious diseases, Knowlegde translation, Viral hepatitis

Molecular & Regenerative Medicine

HIV-1 drug resistance, HIV-1 phylogenetics, HIV-1 subtype, HIV-1 transmission clustering, Integrase inhibitors

Cancer

Cancer biology, Cancer risk, Endocrine therapies, Endocrinology, Hormones, Insulin-like-growth-factors, Metabolism, Nutrition, Oncology, Population studies

National Collaborations and Partnerships